Hemo Organic Limited reported earnings results for the nine months ended December 31, 2022. For the nine months, the company reported sales was INR 0.048 million compared to INR 0.068 million a year ago. Revenue was INR 0.048 million compared to INR 0.068 million a year ago.

Net loss was INR 0.026 million compared to INR 0.55 million a year ago. Basic loss per share from continuing operations was INR 0.01 compared to INR 0.16 a year ago. Diluted loss per share from continuing operations was INR 0.01 compared to INR 0.16 a year ago.